APA (7th ed.) Citation

Garbade, S., Zielonka, M., Mechler, K., Kölker, S., Hoffmann, G. F., Staufner, C., . . . Ries, M. (2020). FDA orphan drug designations for lysosomal storage disorders: A cross sectional analysis. medRxiv. https://doi.org/10.1101/2020.01.05.20016568

Chicago Style (17th ed.) Citation

Garbade, Sven, Matthias Zielonka, Konstantin Mechler, Stefan Kölker, Georg F. Hoffmann, Christian Staufner, Eugen Mengel, and Markus Ries. "FDA Orphan Drug Designations for Lysosomal Storage Disorders: A Cross Sectional Analysis." MedRxiv 2020. https://doi.org/10.1101/2020.01.05.20016568.

MLA (9th ed.) Citation

Garbade, Sven, et al. "FDA Orphan Drug Designations for Lysosomal Storage Disorders: A Cross Sectional Analysis." MedRxiv, 2020, https://doi.org/10.1101/2020.01.05.20016568.